Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]
Sarma I +7 more
europepmc +1 more source
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]
Navari RM +7 more
europepmc +1 more source
High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study. [PDF]
Penati R +4 more
europepmc +1 more source
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy [PDF]
Bastit, P. (P.) +10 more
core +1 more source
Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes. [PDF]
Albanell-Fernández M +8 more
europepmc +1 more source
Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis. [PDF]
Ning C +7 more
europepmc +1 more source
STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian Patients. [PDF]
Shukla P +11 more
europepmc +1 more source
Comprehensive gut microbiota and metabolomics combined with network pharmacology reveal the effects of acupuncture treatment for chemotherapy-induced nausea and vomiting. [PDF]
Wang X, Fan Y, Xiang Y, Zhang S, Yang Y.
europepmc +1 more source
Association of chemotherapy-induced nausea and vomiting or anorexia with plasma levels of five gastrointestinal peptides in patients receiving chemotherapy. [PDF]
Tatsuta R +9 more
europepmc +1 more source

